Literature DB >> 16431926

Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.

Naoto Kubota1, Yasuo Terauchi, Tetsuya Kubota, Hiroki Kumagai, Shinsuke Itoh, Hidemi Satoh, Wataru Yano, Hitomi Ogata, Kumpei Tokuyama, Iseki Takamoto, Tomoka Mineyama, Michiro Ishikawa, Masao Moroi, Kaoru Sugi, Toshimasa Yamauchi, Kohjiro Ueki, Kazuyuki Tobe, Tetsuo Noda, Ryozo Nagai, Takashi Kadowaki.   

Abstract

Thiazolidinediones have been shown to up-regulate adiponectin expression in white adipose tissue and plasma adiponectin levels, and these up-regulations have been proposed to be a major mechanism of the thiazolidinedione-induced amelioration of insulin resistance linked to obesity. To test this hypothesis, we generated adiponectin knock-out (adipo-/-) ob/ob mice with a C57B/6 background. After 14 days of 10 mg/kg pioglitazone, the insulin resistance and diabetes of ob/ob mice were significantly improved in association with significant up-regulation of serum adiponectin levels. Amelioration of insulin resistance in ob/ob mice was attributed to decreased glucose production and increased AMP-activated protein kinase in the liver but not to increased glucose uptake in skeletal muscle. In contrast, insulin resistance and diabetes were not improved in adipo-/-ob/ob mice. After 14 days of 30 mg/kg pioglitazone, insulin resistance and diabetes of ob/ob mice were again significantly ameliorated, which was attributed not only to decreased glucose production in the liver but also to increased glucose uptake in skeletal muscle. Interestingly, adipo-/-ob/ob mice also displayed significant amelioration of insulin resistance and diabetes, which was attributed to increased glucose uptake in skeletal muscle but not to decreased glucose production in the liver. The serum-free fatty acid and triglyceride levels as well as adipocyte sizes in ob/ob and adipo-/-ob/ob mice were unchanged after 10 mg/kg pioglitazone but were significantly reduced to a similar degree after 30 mg/kg pioglitazone. Moreover, the expressions of TNFalpha and resistin in adipose tissues of ob/ob and adipo-/-ob/ob mice were unchanged after 10 mg/kg pioglitazone but were decreased after 30 mg/kg pioglitazone. Thus, pioglitazone-induced amelioration of insulin resistance and diabetes may occur adiponectin dependently in the liver and adiponectin independently in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16431926     DOI: 10.1074/jbc.M505649200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  90 in total

1.  Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats.

Authors:  Pedro L Prieto-Hontoria; Patricia Pérez-Matute; Marta Fernández-Galilea; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Eur J Nutr       Date:  2012-06-05       Impact factor: 5.614

2.  Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.

Authors:  Ajit Vikram; Gopabandhu Jena; Poduri Ramarao
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

3.  Adiponectin is sufficient, but not required, for exercise-induced increases in the expression of skeletal muscle mitochondrial enzymes.

Authors:  Ian R W Ritchie; Tara L MacDonald; David C Wright; David J Dyck
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

Review 4.  Adipocytes as regulators of energy balance and glucose homeostasis.

Authors:  Evan D Rosen; Bruce M Spiegelman
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 5.  The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.

Authors:  Ines Pagel-Langenickel; Jianjun Bao; Liyan Pang; Michael N Sack
Journal:  Endocr Rev       Date:  2009-10-27       Impact factor: 19.871

6.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

7.  Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties.

Authors:  Farid Almabouada; Alberto Diaz-Ruiz; Yoana Rabanal-Ruiz; Juan R Peinado; Rafael Vazquez-Martinez; Maria M Malagon
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

8.  Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}.

Authors:  Gregorio Chazenbalk; Bradley S Trivax; Bulent O Yildiz; Cristina Bertolotto; Ruchi Mathur; Saleh Heneidi; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

9.  Microsomal triglyceride transfer protein inhibition induces endoplasmic reticulum stress and increases gene transcription via Ire1α/cJun to enhance plasma ALT/AST.

Authors:  Joby Josekutty; Jahangir Iqbal; Takao Iwawaki; Kenji Kohno; M Mahmood Hussain
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

10.  Mitochondrial inhibitor as a new class of insulin sensitizer.

Authors:  Yong Zhang; Jianping Ye
Journal:  Acta Pharm Sin B       Date:  2012-08       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.